Literature DB >> 19421224

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

D Ordóñez1, A J Sánchez, J E Martínez-Rodríguez, E Cisneros, E Ramil, N Romo, M Moraru, E Munteis, M López-Botet, J Roquer, A García-Merino, C Vilches.   

Abstract

The genetic susceptibility to multiple sclerosis (MS) is only partially explained, and it shows geographic variations. We analyse here two series of Spanish patients and healthy controls and show that relapsing MS (R-MS) is associated with a gene deletion affecting the hypothetically soluble leukocyte immunoglobulin (Ig)-like receptor A3 (LILRA3, 19q13.4), in agreement with an earlier finding in German patients. Our study points to a gene-dose-dependent, protective role for LILRA3, the deletion of which synergizes with HLA-DRB1(*)1501 to increase the risk of R-MS. We also investigated whether the risk of suffering R-MS might be influenced by the genotypic diversity of killer-cell Ig-like receptors (KIRs), located only approximately 400 kb telomeric to LILRA3, and implicated in autoimmunity and defence against viruses. The relationship of LILRA3 deletion with R-MS is not secondary to linkage disequilibrium with a KIR gene, but we cannot exclude some contributions of KIR to the genetic susceptibility to R-MS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421224     DOI: 10.1038/gene.2009.34

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  18 in total

Review 1.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 2.  Functional and genetic diversity of leukocyte immunoglobulin-like receptor and implication for disease associations.

Authors:  Kouyuki Hirayasu; Hisashi Arase
Journal:  J Hum Genet       Date:  2015-06-04       Impact factor: 3.172

3.  Atlas of human diseases influenced by genetic variants with extreme allele frequency differences.

Authors:  Arvis Sulovari; Yolanda H Chen; James J Hudziak; Dawei Li
Journal:  Hum Genet       Date:  2016-10-03       Impact factor: 4.132

4.  The expression and clinical significance of different forms of LILRA3 in systemic lupus erythematosus.

Authors:  Yan Du; Fengyin Sun; Meiju Zhou; Xinyu Wu; Wenjia Sun; Yujie Jiang; Qi Cheng; Xiaochan Chen; Huaxiang Wu; Jing Xue
Journal:  Clin Rheumatol       Date:  2019-06-17       Impact factor: 2.980

5.  Glycosylation in a mammalian expression system is critical for the production of functionally active leukocyte immunoglobulin-like receptor A3 protein.

Authors:  Terry H Y Lee; Ainslie Mitchell; Sydney Liu Lau; Hongyan An; Poornima Rajeaskariah; Valerie Wasinger; Mark Raftery; Katherine Bryant; Nicodemus Tedla
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

6.  Characterisation of bovine leukocyte Ig-like receptors.

Authors:  Louise Hogan; Sabin Bhuju; Des C Jones; Ken Laing; John Trowsdale; Philip Butcher; Mahavir Singh; Martin Vordermeier; Rachel L Allen
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

7.  Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.

Authors:  Miguel A Ortiz; Concepción Núñez; David Ordóñez; José C Alvarez-Cermeño; José E Martínez-Rodriguez; Antonio J Sánchez; Rafael Arroyo; Guillermo Izquierdo; Sunny Malhotra; Xavier Montalban; Antonio García-Merino; Elvira Munteis; Antonio Alcina; Manuel Comabella; Fuencisla Matesanz; Luisa M Villar; Elena Urcelay
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

8.  Copy number and nucleotide variation of the LILR family of myelomonocytic cell activating and inhibitory receptors.

Authors:  María R López-Álvarez; Des C Jones; Wei Jiang; James A Traherne; John Trowsdale
Journal:  Immunogenetics       Date:  2013-11-21       Impact factor: 2.846

9.  DNA methylation as clinically useful biomarkers-light at the end of the tunnel.

Authors:  Victor V Levenson; Anatoliy A Melnikov
Journal:  Pharmaceuticals (Basel)       Date:  2012-01-18

Review 10.  Prostate cancer in East Asia: evolving trend over the last decade.

Authors:  Yao Zhu; Hong-Kai Wang; Yuan-Yuan Qu; Ding-Wei Ye
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.